![]() |
||||||
|
![]() | Fusion Gene Summary |
![]() | Fusion Gene ORF analysis |
![]() | Fusion Genomic Features |
![]() | Fusion Protein Features |
![]() | Fusion Gene Sequence |
![]() | Fusion Gene PPI analysis |
![]() | Related Drugs |
![]() | Related Diseases |
Fusion gene:CLU-ZBTB18 (FusionGDB2 ID:HG1191TG10472) |
Fusion Gene Summary for CLU-ZBTB18 |
![]() |
Fusion gene information | Fusion gene name: CLU-ZBTB18 | Fusion gene ID: hg1191tg10472 | Hgene | Tgene | Gene symbol | CLU | ZBTB18 | Gene ID | 1191 | 10472 |
Gene name | clusterin | zinc finger and BTB domain containing 18 | |
Synonyms | AAG4|APO-J|APOJ|CLI|CLU1|CLU2|KUB1|NA1/NA2|SGP-2|SGP2|SP-40|TRPM-2|TRPM2 | C2H2-171|MRD22|RP58|TAZ-1|ZNF238 | |
Cytomap | ('CLU')('ZBTB18') 8p21.1 | 1q44 | |
Type of gene | protein-coding | protein-coding | |
Description | clusterinaging-associated protein 4apolipoprotein Jcomplement cytolysis inhibitorcomplement lysis inhibitorcomplement-associated protein SP-40,40epididymis secretory sperm binding proteinku70-binding protein 1sulfated glycoprotein 2testosterone-r | zinc finger and BTB domain-containing protein 1858 kDa repressor proteintranscriptional repressor RP58translin-associated zinc finger protein 1zinc finger protein 238zinc finger protein C2H2-171 | |
Modification date | 20200327 | 20200315 | |
UniProtAcc | P10909 | . | |
Ensembl transtripts involved in fusion gene | ENST00000316403, ENST00000405140, ENST00000523500, ENST00000546343, ENST00000560366, | ||
Fusion gene scores | * DoF score | 38 X 38 X 12=17328 | 6 X 4 X 3=72 |
# samples | 49 | 5 | |
** MAII score | log2(49/17328*10)=-5.14417958860576 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(5/72*10)=-0.526068811667588 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: CLU [Title/Abstract] AND ZBTB18 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | CLU(27455605)-ZBTB18(244217614), # samples:2 | ||
Anticipated loss of major functional domain due to fusion event. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | CLU | GO:0000902 | cell morphogenesis | 15857407 |
Hgene | CLU | GO:0001774 | microglial cell activation | 15857407 |
Hgene | CLU | GO:0017038 | protein import | 24446231 |
Hgene | CLU | GO:0031333 | negative regulation of protein complex assembly | 22179788|23106396 |
Hgene | CLU | GO:0031334 | positive regulation of protein complex assembly | 22179788 |
Hgene | CLU | GO:0032760 | positive regulation of tumor necrosis factor production | 15857407 |
Hgene | CLU | GO:0045429 | positive regulation of nitric oxide biosynthetic process | 15857407 |
Hgene | CLU | GO:0050821 | protein stabilization | 11123922|12176985 |
Hgene | CLU | GO:0051131 | chaperone-mediated protein complex assembly | 17412999 |
Hgene | CLU | GO:0051788 | response to misfolded protein | 19996109 |
Hgene | CLU | GO:0061077 | chaperone-mediated protein folding | 11123922 |
Hgene | CLU | GO:0061518 | microglial cell proliferation | 15857407 |
Hgene | CLU | GO:1900221 | regulation of amyloid-beta clearance | 24446231 |
Hgene | CLU | GO:1901214 | regulation of neuron death | 17412999 |
Hgene | CLU | GO:1901216 | positive regulation of neuron death | 15857407 |
Hgene | CLU | GO:1902430 | negative regulation of amyloid-beta formation | 12047389|17412999 |
Hgene | CLU | GO:1905907 | negative regulation of amyloid fibril formation | 22179788 |
Tgene | ZBTB18 | GO:0045944 | positive regulation of transcription by RNA polymerase II | 25796446 |
![]() * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
Top |
Fusion Gene ORF analysis for CLU-ZBTB18 |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
Top |
Fusion Genomic Features for CLU-ZBTB18 |
![]() |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
Top |
Fusion Protein Features for CLU-ZBTB18 |
![]() Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/:27455605/:244217614) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
![]() |
Hgene | Tgene |
CLU | . |
FUNCTION: [Isoform 1]: Functions as extracellular chaperone that prevents aggregation of non native proteins (PubMed:11123922, PubMed:19535339). Prevents stress-induced aggregation of blood plasma proteins (PubMed:11123922, PubMed:12176985, PubMed:17260971, PubMed:19996109). Inhibits formation of amyloid fibrils by APP, APOC2, B2M, CALCA, CSN3, SNCA and aggregation-prone LYZ variants (in vitro) (PubMed:12047389, PubMed:17412999, PubMed:17407782). Does not require ATP (PubMed:11123922). Maintains partially unfolded proteins in a state appropriate for subsequent refolding by other chaperones, such as HSPA8/HSC70 (PubMed:11123922). Does not refold proteins by itself (PubMed:11123922). Binding to cell surface receptors triggers internalization of the chaperone-client complex and subsequent lysosomal or proteasomal degradation (PubMed:21505792). Protects cells against apoptosis and against cytolysis by complement (PubMed:2780565). Intracellular forms interact with ubiquitin and SCF (SKP1-CUL1-F-box protein) E3 ubiquitin-protein ligase complexes and promote the ubiquitination and subsequent proteasomal degradation of target proteins (PubMed:20068069). Promotes proteasomal degradation of COMMD1 and IKBKB (PubMed:20068069). Modulates NF-kappa-B transcriptional activity (PubMed:12882985). A mitochondrial form suppresses BAX-dependent release of cytochrome c into the cytoplasm and inhibit apoptosis (PubMed:16113678, PubMed:17689225). Plays a role in the regulation of cell proliferation (PubMed:19137541). An intracellular form suppresses stress-induced apoptosis by stabilizing mitochondrial membrane integrity through interaction with HSPA5 (PubMed:22689054). Secreted form does not affect caspase or BAX-mediated intrinsic apoptosis and TNF-induced NF-kappa-B-activity (PubMed:24073260). Secreted form act as an important modulator during neuronal differentiation through interaction with STMN3 (By similarity). Plays a role in the clearance of immune complexes that arise during cell injury (By similarity). {ECO:0000250|UniProtKB:P05371, ECO:0000250|UniProtKB:Q06890, ECO:0000269|PubMed:11123922, ECO:0000269|PubMed:12047389, ECO:0000269|PubMed:12176985, ECO:0000269|PubMed:12882985, ECO:0000269|PubMed:16113678, ECO:0000269|PubMed:17260971, ECO:0000269|PubMed:17407782, ECO:0000269|PubMed:17412999, ECO:0000269|PubMed:17689225, ECO:0000269|PubMed:19137541, ECO:0000269|PubMed:19535339, ECO:0000269|PubMed:19996109, ECO:0000269|PubMed:20068069, ECO:0000269|PubMed:21505792, ECO:0000269|PubMed:22689054, ECO:0000269|PubMed:24073260, ECO:0000269|PubMed:2780565}.; FUNCTION: [Isoform 6]: Does not affect caspase or BAX-mediated intrinsic apoptosis and TNF-induced NF-kappa-B-activity. {ECO:0000269|PubMed:24073260}.; FUNCTION: [Isoform 4]: Does not affect caspase or BAX-mediated intrinsic apoptosis and TNF-induced NF-kappa-B-activity (PubMed:24073260). Promotes cell death through interaction with BCL2L1 that releases and activates BAX (PubMed:21567405). {ECO:0000269|PubMed:21567405, ECO:0000269|PubMed:24073260}. | FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
Fusion Gene Sequence for CLU-ZBTB18 |
![]() |
Top |
Fusion Gene PPI Analysis for CLU-ZBTB18 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for CLU-ZBTB18 |
![]() (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Hgene | CLU | P10909 | DB14548 | Zinc sulfate, unspecified form | Inducer | Small molecule | Approved|Experimental |
Hgene | CLU | P10909 | DB14548 | Zinc sulfate, unspecified form | Inducer | Small molecule | Approved|Experimental |
Hgene | CLU | P10909 | DB14548 | Zinc sulfate, unspecified form | Inducer | Small molecule | Approved|Experimental |
Hgene | CLU | P10909 | DB14548 | Zinc sulfate, unspecified form | Inducer | Small molecule | Approved|Experimental |
Hgene | CLU | P10909 | DB14548 | Zinc sulfate, unspecified form | Inducer | Small molecule | Approved|Experimental |
Hgene | CLU | P10909 | DB01593 | Zinc | Small molecule | Approved|Investigational | |
Hgene | CLU | P10909 | DB01593 | Zinc | Small molecule | Approved|Investigational | |
Hgene | CLU | P10909 | DB01593 | Zinc | Small molecule | Approved|Investigational | |
Hgene | CLU | P10909 | DB01593 | Zinc | Small molecule | Approved|Investigational | |
Hgene | CLU | P10909 | DB01593 | Zinc | Small molecule | Approved|Investigational | |
Hgene | CLU | P10909 | DB09130 | Copper | Small molecule | Approved|Investigational | |
Hgene | CLU | P10909 | DB09130 | Copper | Small molecule | Approved|Investigational | |
Hgene | CLU | P10909 | DB09130 | Copper | Small molecule | Approved|Investigational | |
Hgene | CLU | P10909 | DB09130 | Copper | Small molecule | Approved|Investigational | |
Hgene | CLU | P10909 | DB09130 | Copper | Small molecule | Approved|Investigational | |
Hgene | CLU | P10909 | DB14487 | Zinc acetate | Small molecule | Approved|Investigational | |
Hgene | CLU | P10909 | DB14487 | Zinc acetate | Small molecule | Approved|Investigational | |
Hgene | CLU | P10909 | DB14487 | Zinc acetate | Small molecule | Approved|Investigational | |
Hgene | CLU | P10909 | DB14487 | Zinc acetate | Small molecule | Approved|Investigational | |
Hgene | CLU | P10909 | DB14487 | Zinc acetate | Small molecule | Approved|Investigational | |
Hgene | CLU | P10909 | DB14533 | Zinc chloride | Inducer | Small molecule | Approved|Investigational |
Hgene | CLU | P10909 | DB14533 | Zinc chloride | Inducer | Small molecule | Approved|Investigational |
Hgene | CLU | P10909 | DB14533 | Zinc chloride | Inducer | Small molecule | Approved|Investigational |
Hgene | CLU | P10909 | DB14533 | Zinc chloride | Inducer | Small molecule | Approved|Investigational |
Hgene | CLU | P10909 | DB14533 | Zinc chloride | Inducer | Small molecule | Approved|Investigational |
Top |
Related Diseases for CLU-ZBTB18 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | CLU | C0022660 | Kidney Failure, Acute | 6 | CTD_human |
Hgene | CLU | C1565662 | Acute Kidney Insufficiency | 6 | CTD_human |
Hgene | CLU | C2609414 | Acute kidney injury | 6 | CTD_human |
Hgene | CLU | C0002395 | Alzheimer's Disease | 3 | CTD_human |
Hgene | CLU | C0011265 | Presenile dementia | 3 | CTD_human |
Hgene | CLU | C0022658 | Kidney Diseases | 3 | CTD_human |
Hgene | CLU | C0276496 | Familial Alzheimer Disease (FAD) | 3 | CTD_human |
Hgene | CLU | C0494463 | Alzheimer Disease, Late Onset | 3 | CTD_human |
Hgene | CLU | C0546126 | Acute Confusional Senile Dementia | 3 | CTD_human |
Hgene | CLU | C0750900 | Alzheimer's Disease, Focal Onset | 3 | CTD_human |
Hgene | CLU | C0750901 | Alzheimer Disease, Early Onset | 3 | CTD_human |
Hgene | CLU | C0013221 | Drug toxicity | 2 | CTD_human |
Hgene | CLU | C0029408 | Degenerative polyarthritis | 2 | CTD_human |
Hgene | CLU | C0041755 | Adverse reaction to drug | 2 | CTD_human |
Hgene | CLU | C0086743 | Osteoarthrosis Deformans | 2 | CTD_human |
Hgene | CLU | C0019193 | Hepatitis, Toxic | 1 | CTD_human |
Hgene | CLU | C0022333 | Jacksonian Seizure | 1 | CTD_human |
Hgene | CLU | C0024141 | Lupus Erythematosus, Systemic | 1 | CTD_human |
Hgene | CLU | C0025202 | melanoma | 1 | CTD_human |
Hgene | CLU | C0027686 | Pathologic Neovascularization | 1 | CTD_human |
Hgene | CLU | C0033578 | Prostatic Neoplasms | 1 | CTD_human |
Hgene | CLU | C0036341 | Schizophrenia | 1 | PSYGENET |
Hgene | CLU | C0036572 | Seizures | 1 | CTD_human |
Hgene | CLU | C0087031 | Juvenile-Onset Still Disease | 1 | CTD_human |
Hgene | CLU | C0149958 | Complex partial seizures | 1 | CTD_human |
Hgene | CLU | C0234533 | Generalized seizures | 1 | CTD_human |
Hgene | CLU | C0234535 | Clonic Seizures | 1 | CTD_human |
Hgene | CLU | C0234985 | Mental deterioration | 1 | CTD_human |
Hgene | CLU | C0242380 | Libman-Sacks Disease | 1 | CTD_human |
Hgene | CLU | C0270824 | Visual seizure | 1 | CTD_human |
Hgene | CLU | C0270844 | Tonic Seizures | 1 | CTD_human |
Hgene | CLU | C0270846 | Epileptic drop attack | 1 | CTD_human |
Hgene | CLU | C0333641 | Atrophic | 1 | CTD_human |
Hgene | CLU | C0338656 | Impaired cognition | 1 | CTD_human |
Hgene | CLU | C0376358 | Malignant neoplasm of prostate | 1 | CTD_human |
Hgene | CLU | C0422850 | Seizures, Somatosensory | 1 | CTD_human |
Hgene | CLU | C0422852 | Seizures, Auditory | 1 | CTD_human |
Hgene | CLU | C0422853 | Olfactory seizure | 1 | CTD_human |
Hgene | CLU | C0422854 | Gustatory seizure | 1 | CTD_human |
Hgene | CLU | C0422855 | Vertiginous seizure | 1 | CTD_human |
Hgene | CLU | C0494475 | Tonic - clonic seizures | 1 | CTD_human |
Hgene | CLU | C0751056 | Non-epileptic convulsion | 1 | CTD_human |
Hgene | CLU | C0751110 | Single Seizure | 1 | CTD_human |
Hgene | CLU | C0751123 | Atonic Absence Seizures | 1 | CTD_human |
Hgene | CLU | C0751494 | Convulsive Seizures | 1 | CTD_human |
Hgene | CLU | C0751495 | Seizures, Focal | 1 | CTD_human |
Hgene | CLU | C0751496 | Seizures, Sensory | 1 | CTD_human |
Hgene | CLU | C0860207 | Drug-Induced Liver Disease | 1 | CTD_human |
Hgene | CLU | C1262760 | Hepatitis, Drug-Induced | 1 | CTD_human |
Hgene | CLU | C1270972 | Mild cognitive disorder | 1 | CTD_human |
Hgene | CLU | C1862939 | AMYOTROPHIC LATERAL SCLEROSIS 1 | 1 | CTD_human |
Hgene | CLU | C1862941 | Amyotrophic Lateral Sclerosis, Sporadic | 1 | CTD_human |
Hgene | CLU | C3495559 | Juvenile arthritis | 1 | CTD_human |
Hgene | CLU | C3495874 | Nonepileptic Seizures | 1 | CTD_human |
Hgene | CLU | C3658290 | Drug-Induced Acute Liver Injury | 1 | CTD_human |
Hgene | CLU | C3714758 | Juvenile psoriatic arthritis | 1 | CTD_human |
Hgene | CLU | C4048158 | Convulsions | 1 | CTD_human |
Hgene | CLU | C4277682 | Chemical and Drug Induced Liver Injury | 1 | CTD_human |
Hgene | CLU | C4279912 | Chemically-Induced Liver Toxicity | 1 | CTD_human |
Hgene | CLU | C4316903 | Absence Seizures | 1 | CTD_human |
Hgene | CLU | C4317109 | Epileptic Seizures | 1 | CTD_human |
Hgene | CLU | C4317123 | Myoclonic Seizures | 1 | CTD_human |
Hgene | CLU | C4505436 | Generalized Absence Seizures | 1 | CTD_human |
Hgene | CLU | C4551993 | Amyotrophic Lateral Sclerosis, Familial | 1 | CTD_human |
Hgene | CLU | C4552091 | Polyarthritis, Juvenile, Rheumatoid Factor Negative | 1 | CTD_human |
Hgene | CLU | C4704862 | Polyarthritis, Juvenile, Rheumatoid Factor Positive | 1 | CTD_human |
Tgene | C3808184 | MENTAL RETARDATION, AUTOSOMAL DOMINANT 22 | 2 | CTD_human;GENOMICS_ENGLAND | |
Tgene | C0557874 | Global developmental delay | 1 | GENOMICS_ENGLAND | |
Tgene | C4273897 | Distal monosomy 1q | 1 | ORPHANET |